For pharmaceutical industry veterans, November 2023 marks the end of a decade-long journey to “achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States.” This milestone will come with little fanfare, but with gigantic impact to the pharmaceutical supply chain.
Many major wholesalers are leading the charge for receiving aggregated data—requiring that manufacturers be able to digitally send pallet identifiers with corresponding digital details of all shipments sent to them. Without this data being aggregated, wholesale staff would have to open each pallet and manually scan each serialized product.
Many New Year’s Resolutions are still in full force! January’s optimism is holding strong with uncluttered calendars, new gym memberships and a sense of renewal and improvement.
Protecting the integrity of a brand is a multifaceted discipline which can be complicated by many pressing issues. Not least is tackling counterfeiting and diversion, as well as meeting high standards of traceability. When Systech was approached by a leading e-nicotine delivery system (ENDS) company, we worked in partnership with them to protect their brand and support business growth.
In an interview for the Vantage Solves Series I explained why November 27, 2023 is critical for the pharmaceutical supply chain. By this date members of the ecosystem must implement an electronic, interoperable system to identify and trace prescription drug products in the US to be compliant with the Drug Supply Chain Security Act (DSCSA). Additionally, wholesale distributors will require aggregation data to accept product in the coming year.
Preface: In this blog I’m going to assert that “the data associated with the drug and its supply chain transactions is just as important as the drug itself.” Disclaimer: The drug is certainly the most important part in the patient healthcare equation—data has nothing to do with that. BUT… there is a comprehensive data collection and integration reality that is required to get these drugs through the supply chain and eventually to the patients who need them. Ultimately, regulations like the...
Brazil is a vibrant market packed with opportunities. Markem-Image is meeting the needs of our customers by combining our traditional expertise with investment in new technology writes Julio Leite, Markem-Imaje’s Regional Sales Director for Brazil and Argentina.
Systech technology allows manufacturers to add a digital layer of protection to their products that is impossible to counterfeit. As it is based on an already existing mark, our innovative solution is non-additive, representing substantial cost savings.LUX Global Label is a leading manufacturer of pressure-sensitive labels, shrink sleeves and security solutions whose customers include many of the world’s most trusted brands. In 2020, LUX initiated a highly fruitful collaboration with...
When Spanish wire manufacturers Cables RCT identified opportunities for improvement in its complex marking and coding processes, it turned to Markem-Imaje for solutions.
Wellness! It’s the consumer word of our times and the noun that has sold a thousand products: from vitamin supplements to fitness products and snacks. Whilst the shift over the last decade to personal wellness and hypervigilance of what we put in our bodies is well documented, less well known is the growing trend for wellness in pet products.